Evidence map›Paper›PMID 31355633›Full record

ArticleAnalytical chemistry2019

Enhanced Sensitivity Using MALDI Imaging Coupled with Laser Postionization (MALDI-2) for Pharmaceutical Research.

Florian P Y Barré, Martin R L Paine, Bryn Flinders, Adam J Trevitt, Patricia D Kelly, Rima Ait-Belkacem, João P Garcia, Laura B Creemers, Jonathan Stauber, Rob J Vreeken and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Analytical chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Enhancing the Sensitivity of Mass Spectrometry Imaging through Spatial Signal Averaging.Journal of the American Society for Mass Spectrometry · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Mass Spectrometry Imaging.Analytical chemistry · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Quantitative mass spectrometry imaging: therapeutics & biomolecules.Chemical communications (Cambridge, England) · 2024
    Review
  16. Review
  17. Spatial pharmacology using mass spectrometry imaging.Trends in pharmacological sciences · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Florian P Y BarréThe Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , Universiteitssingel 50 , 6229 ER Maastricht , The Netherlands.
Martin R L PaineThe Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , Universiteitssingel 50 , 6229 ER Maastricht , The Netherlands.
Bryn FlindersThe Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , Universiteitssingel 50 , 6229 ER Maastricht , The Netherlands.
Adam J TrevittSchool of Chemistry , University of Wollongong , Wollongong , Australia.ORCID 0000-0003-2525-3162
Patricia D KellySchool of Chemistry , University of Wollongong , Wollongong , Australia.
Rima Ait-BelkacemImaBiotech , Loos , France.
João P GarciaUniversity Medical Centre (UMC) Utrecht , Department of Orthopedics , Heidelberglaan 100 , 3584 CX Utrecht , The Netherlands.
Laura B CreemersUniversity Medical Centre (UMC) Utrecht , Department of Orthopedics , Heidelberglaan 100 , 3584 CX Utrecht , The Netherlands.
Jonathan StauberImaBiotech , Loos , France.
Rob J VreekenThe Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , Universiteitssingel 50 , 6229 ER Maastricht , The Netherlands.
Berta Cillero-PastorThe Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , Universiteitssingel 50 , 6229 ER Maastricht , The Netherlands.ORCID 0000-0002-7407-1165
Shane R EllisThe Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , Universiteitssingel 50 , 6229 ER Maastricht , The Netherlands.ORCID 0000-0002-3326-5991
Ron M A HeerenThe Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , Universiteitssingel 50 , 6229 ER Maastricht , The Netherlands.ORCID 0000-0002-6533-7179
Maastricht University · NLUniversity Medical Center Utrecht · NLUniversity of Wollongong · AUJanssen (Belgium) · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Visualizing the distributions of drugs and their metabolites is one of the key emerging application areas of matrix-assisted laser desorption/ionization-mass spectrometry imaging (MALDI-MSI) within pharmaceutical research. The success of a given MALDI-MSI experiment is ultimately determined by the ionization efficiency of the compounds of interest, which in many cases are too low to enable detection at relevant concentrations. In this work we have taken steps to address this challenge via the first application of laser-postionisation coupled with MALDI (so-called MALDI-2) to the analysis and imaging of pharmaceutical compounds. We demonstrate that MALDI-2 increased the signal intensities for 7 out of the 10 drug compounds analyzed by up to 2 orders of magnitude compared to conventional MALDI analysis. This gain in sensitivity enabled the distributions of drug compounds in both human cartilage and dog liver tissue to be visualized using MALDI-2, whereas little-to-no signal from tissue was obtained using conventional MALDI. This work demonstrates the vast potential of MALDI-2-MSI in pharmaceutical research and drug development and provides a valuable tool to broaden the application areas of MSI. Finally, in an effort to understand the ionization mechanism, we provide the first evidence that the preferential formation of [M + H]

Indexed as

LasersPharmaceutical ResearchAnimalsCartilageDogsHumansLiverPharmaceutical PreparationsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationPharmaceutical Preparations

Identifiers

PMID31355633
PMCPMC6706868
OpenAlexW2964941523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.